Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1384959

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1384959

Europe Non-invasive Prenatal Testing (NIPT) Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End User (Diagnostic Laboratories, Hospitals & Clinics), By Technology, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Non-invasive Prenatal Testing (NIPT) Market would witness market growth of 17.7% CAGR during the forecast period (2023-2030).

NIPT can be carried out as early as 9-10 weeks into pregnancy, giving parents and medical professionals access to vital information about the unborn child's health earlier and facilitating early interventions. NIPT is not limited to a single disorder; it can detect a wide range of chromosomal abnormalities, including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), and sex chromosome disorders. The reduced false-positive rate of NIPT results in fewer unnecessary follow-up tests and the associated anxiety for expectant parents.

The growing understanding of the technology has contributed significantly to its adoption. NIPT is now more widely available and less expensive for a wider variety of pregnant women because many insurance companies fund it. Chromosome abnormalities such as Down, Edwards, Patau, and sex chromosome diseases are primarily detected via NIPT. By analyzing cell-free DNA from the foetus in the mother's bloodstream, NIPT accurately assesses the baby's chromosomal health. NIPT can accurately determine the sex of the foetus. This information is valuable for parents who wish to know the gender of their baby and for medical reasons, such as sex-linked genetic conditions.

Prenatal care in Europe has generally been well-established and accessible, focusing on ensuring the mother's and developing foetus's health and well-being. According to the 2022 data from the National Health Service England, the NHS in England has announced that maternity services across England will receive a funding boost of £127 million, which will assist in providing safer and more individualized care for women and their newborns. Thus, an increase in the cases of Down's syndrome in Europe and rising prenatal care investment will boost the demand for these in the region.

The Germany market dominated the Europe Non-invasive Prenatal Testing (NIPT) Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,133.5 Million by 2030. The UK market is exhibiting a CAGR of 16.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 18.6% during (2023 - 2030).

Based on Product, the market is segmented into Consumables & Reagents, and Instruments. Based on Application, the market is segmented into Trisomy, Microdeletion Syndrome, and Others. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics. Based on Technology, the market is segmented into Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Natera Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Thermo Fisher Scientific, Inc., GE HealthCare Technologies, Inc., Agilent Technologies, Inc., and Pacific Biosciences of California, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Consumables & Reagents
  • Instruments

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Others

By End User

  • Diagnostic Laboratories
  • Hospitals & Clinics

By Technology

  • Next Generation Sequencing (NGS)
  • Microarray
  • Polymerase Chain Reaction (PCR)
  • Rolling Circular Amplification

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Illumina, Inc.
  • Natera Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • GE HealthCare Technologies, Inc.
  • Agilent Technologies, Inc.
  • Pacific Biosciences of California, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Non-invasive Prenatal Testing (NIPT) Market, by Product
    • 1.4.2 Europe Non-invasive Prenatal Testing (NIPT) Market, by Application
    • 1.4.3 Europe Non-invasive Prenatal Testing (NIPT) Market, by End User
    • 1.4.4 Europe Non-invasive Prenatal Testing (NIPT) Market, by Technology
    • 1.4.5 Europe Non-invasive Prenatal Testing (NIPT) Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. Europe Non-invasive Prenatal Testing (NIPT) Market by Product

  • 4.1 Europe Consumables & Reagents Market by Country
  • 4.2 Europe Instruments Market by Country

Chapter 5. Europe Non-invasive Prenatal Testing (NIPT) Market by Application

  • 5.1 Europe Trisomy Market by Country
  • 5.2 Europe Microdeletion Syndrome Market by Country
  • 5.3 Europe Others Market by Country

Chapter 6. Europe Non-invasive Prenatal Testing (NIPT) Market by End User

  • 6.1 Europe Diagnostic Laboratories Market by Country
  • 6.2 Europe Hospitals & Clinics Market by Country

Chapter 7. Europe Non-invasive Prenatal Testing (NIPT) Market by Technology

  • 7.1 Europe Next Generation Sequencing (NGS) Market by Country
  • 7.2 Europe Microarray Market by Country
  • 7.3 Europe Polymerase Chain Reaction (PCR) Market by Country
  • 7.4 Europe Rolling Circular Amplification Market by Country

Chapter 8. Europe Non-invasive Prenatal Testing (NIPT) Market by Country

  • 8.1 Germany Non-invasive Prenatal Testing (NIPT) Market
    • 8.1.1 Germany Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.1.2 Germany Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.1.3 Germany Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.1.4 Germany Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.2 UK Non-invasive Prenatal Testing (NIPT) Market
    • 8.2.1 UK Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.2.2 UK Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.2.3 UK Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.2.4 UK Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.3 France Non-invasive Prenatal Testing (NIPT) Market
    • 8.3.1 France Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.3.2 France Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.3.3 France Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.3.4 France Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.4 Russia Non-invasive Prenatal Testing (NIPT) Market
    • 8.4.1 Russia Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.4.2 Russia Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.4.3 Russia Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.4.4 Russia Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.5 Spain Non-invasive Prenatal Testing (NIPT) Market
    • 8.5.1 Spain Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.5.2 Spain Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.5.3 Spain Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.5.4 Spain Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.6 Italy Non-invasive Prenatal Testing (NIPT) Market
    • 8.6.1 Italy Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.6.2 Italy Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.6.3 Italy Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.6.4 Italy Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.7 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market
    • 8.7.1 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.7.2 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.7.3 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.7.4 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Technology

Chapter 9. Company Profiles

  • 9.1 Illumina, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 Natera Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 F. Hoffmann-La Roche Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 SWOT Analysis
  • 9.4 PerkinElmer, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Acquisition and Mergers:
    • 9.4.6 SWOT Analysis
  • 9.5 Laboratory Corporation of America Holdings
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental Analysis
    • 9.5.4 SWOT Analysis
  • 9.6 Eurofins Scientific SE
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Recent strategies and developments:
      • 9.6.4.1 Product Launches and Product Expansions:
    • 9.6.5 SWOT Analysis
  • 9.7 Thermo Fisher Scientific, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 WOT Analysis
  • 9.8 GE HealthCare Technologies, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Product Launches and Product Expansions:
      • 9.8.5.2 Acquisition and Mergers:
    • 9.8.6 SWOT Analysis
  • 9.9 Agilent Technologies, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis
  • 9.10. Pacific Biosciences of California, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 Recent strategies and developments:
      • 9.10.5.1 Acquisition and Mergers:
    • 9.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Europe Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 2 Europe Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 3 Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 4 Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 5 Europe Consumables & Reagents Market by Country, 2019 - 2022, USD Million
  • TABLE 6 Europe Consumables & Reagents Market by Country, 2023 - 2030, USD Million
  • TABLE 7 Europe Instruments Market by Country, 2019 - 2022, USD Million
  • TABLE 8 Europe Instruments Market by Country, 2023 - 2030, USD Million
  • TABLE 9 Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 10 Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 11 Europe Trisomy Market by Country, 2019 - 2022, USD Million
  • TABLE 12 Europe Trisomy Market by Country, 2023 - 2030, USD Million
  • TABLE 13 Europe Microdeletion Syndrome Market by Country, 2019 - 2022, USD Million
  • TABLE 14 Europe Microdeletion Syndrome Market by Country, 2023 - 2030, USD Million
  • TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 16 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 17 Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 18 Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 19 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 20 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 21 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 22 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 23 Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 24 Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 25 Europe Next Generation Sequencing (NGS) Market by Country, 2019 - 2022, USD Million
  • TABLE 26 Europe Next Generation Sequencing (NGS) Market by Country, 2023 - 2030, USD Million
  • TABLE 27 Europe Microarray Market by Country, 2019 - 2022, USD Million
  • TABLE 28 Europe Microarray Market by Country, 2023 - 2030, USD Million
  • TABLE 29 Europe Polymerase Chain Reaction (PCR) Market by Country, 2019 - 2022, USD Million
  • TABLE 30 Europe Polymerase Chain Reaction (PCR) Market by Country, 2023 - 2030, USD Million
  • TABLE 31 Europe Rolling Circular Amplification Market by Country, 2019 - 2022, USD Million
  • TABLE 32 Europe Rolling Circular Amplification Market by Country, 2023 - 2030, USD Million
  • TABLE 33 Europe Non-invasive Prenatal Testing (NIPT) Market by Country, 2019 - 2022, USD Million
  • TABLE 34 Europe Non-invasive Prenatal Testing (NIPT) Market by Country, 2023 - 2030, USD Million
  • TABLE 35 Germany Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 36 Germany Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 37 Germany Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 38 Germany Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 39 Germany Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 40 Germany Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 41 Germany Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 42 Germany Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 43 Germany Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 44 Germany Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 45 UK Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 46 UK Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 47 UK Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 48 UK Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 49 UK Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 50 UK Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 51 UK Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 52 UK Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 53 UK Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 54 UK Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 55 France Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 56 France Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 57 France Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 58 France Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 59 France Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 60 France Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 61 France Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 62 France Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 63 France Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 64 France Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 65 Russia Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 66 Russia Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 67 Russia Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 68 Russia Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 69 Russia Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 70 Russia Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 71 Russia Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 72 Russia Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 73 Russia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 74 Russia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 75 Spain Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 76 Spain Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 77 Spain Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 78 Spain Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 79 Spain Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 80 Spain Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 81 Spain Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 82 Spain Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 83 Spain Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 84 Spain Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 85 Italy Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 86 Italy Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 87 Italy Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 88 Italy Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 89 Italy Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 90 Italy Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 91 Italy Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 92 Italy Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 93 Italy Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 94 Italy Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 95 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 96 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 97 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 98 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 99 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 100 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 101 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 102 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 103 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 104 Rest of Europe Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 105 key information - Illumina, Inc.
  • TABLE 106 Key Information - Natera Inc.
  • TABLE 107 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 108 key Information - PerkinElmer, Inc.
  • TABLE 109 Key Information - Laboratory Corporation of America holdings
  • TABLE 110 Key Information - Eurofins Scientific SE
  • TABLE 111 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 112 Key Information - GE HealthCare Technologies, Inc.
  • TABLE 113 key Information - Agilent Technologies, Inc.
  • TABLE 114 Key Information - Pacific Biosciences of California, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!